These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 16921553

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. SRE1 and SRE2 are two specific steroid-responsive modules of Candida drug resistance gene 1 (CDR1) promoter.
    Karnani N, Gaur NA, Jha S, Puri N, Krishnamurthy S, Goswami SK, Mukhopadhyay G, Prasad R.
    Yeast; 2004 Feb; 21(3):219-39. PubMed ID: 14968428
    [Abstract] [Full Text] [Related]

  • 3. Serum repressing efflux pump CDR1 in Candida albicans.
    Yang YL, Lin YH, Tsao MY, Chen CG, Shih HI, Fan JC, Wang JS, Lo HJ.
    BMC Mol Biol; 2006 Jul 13; 7():22. PubMed ID: 16839415
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adriamycin alters the expression of drug efflux pumps and confers amphotericin B tolerance in Candida albicans.
    O'Keeffe J, Kavanagh K.
    Anticancer Res; 2004 Jul 13; 24(2A):405-8. PubMed ID: 15152937
    [Abstract] [Full Text] [Related]

  • 8. Doxorubicin induces drug efflux pumps in Candida albicans.
    Kofla G, Turner V, Schulz B, Storch U, Froelich D, Rognon B, Coste AT, Sanglard D, Ruhnke M.
    Med Mycol; 2011 Feb 13; 49(2):132-42. PubMed ID: 20818920
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Genome-wide expression profiling of the response to terbinafine in Candida albicans using a cDNA microarray analysis.
    Zeng YB, Qian YS, Ma L, Gu HN.
    Chin Med J (Engl); 2007 May 05; 120(9):807-13. PubMed ID: 17531123
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. RTA2, a novel gene involved in azole resistance in Candida albicans.
    Jia XM, Ma ZP, Jia Y, Gao PH, Zhang JD, Wang Y, Xu YG, Wang L, Cao YY, Cao YB, Zhang LX, Jiang YY.
    Biochem Biophys Res Commun; 2008 Sep 05; 373(4):631-6. PubMed ID: 18601908
    [Abstract] [Full Text] [Related]

  • 17. Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans.
    Lee RE, Liu TT, Barker KS, Lee RE, Rogers PD.
    J Antimicrob Chemother; 2005 May 05; 55(5):655-62. PubMed ID: 15814599
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.
    Maurya IK, Thota CK, Verma SD, Sharma J, Rawal MK, Ravikumar B, Sen S, Chauhan N, Lynn AM, Chauhan VS, Prasad R.
    J Biol Chem; 2013 Jun 07; 288(23):16775-16787. PubMed ID: 23592791
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.